The Intelligent Supply Chain
August 2018

August 2018

The combination of new drugs, new treatments and advanced data analytics solutions creates superior opportunities for patients, making treatment more effective, more affordable and less intrusive, with a positive impact on quality of life. Distribution and drug consumption models are rapidly changing with the emergence of new business avenues around individualized medicine, combination therapies, device/drug convergence, etc. In this article, Marc Herlant of Arthur D. Little, discusses how the intelligent pharmaceutical supply chain can enable a superior patient-and-caregiver experience.